← Eichor
Condition: Kidney Transplant Failure And Rejection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Kidney Transplant Failure And Rejection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Phase 1/Phase 2 · 9 location(s) · Eledon Pharmaceuticals · NCT05027906Empagliflozin Treatment in Kidney Transplant Recipients
Phase 4 · 5 location(s) · VA Office of Research and Development · NCT06013865Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507Tacrolimus Pharmacokinetic Subpopulations
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT04526431Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated
NA · 1 location(s) · Hospices Civils de Lyon · NCT03955172Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Phase N/A · 1 location(s) · Liverpool University Hospitals NHS Foundation Trust · NCT06025240A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Phase 3 · 13 location(s) · The University of Queensland · NCT05325008TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06801262Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
Phase N/A · 1 location(s) · Loma Linda University · NCT05084768A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
Phase 2 · 2 location(s) · Nefro Avillion Clinical Development, LLC · NCT07508787CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Phase 1/Phase 2 · 1 location(s) · AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · NCT07053462Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to S
Phase 4 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06676696
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.